Details
Stereochemistry | RACEMIC |
Molecular Formula | C28H40N2O5.ClH |
Molecular Weight | 521.089 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC(=CC(OC)=C1OC)C(CCCN(C)CCC2=CC(OC)=C(OC)C=C2)(C#N)C(C)C
InChI
InChIKey=OKCRIUNHEQSXFD-UHFFFAOYSA-N
InChI=1S/C28H40N2O5.ClH/c1-20(2)28(19-29,22-17-25(33-6)27(35-8)26(18-22)34-7)13-9-14-30(3)15-12-21-10-11-23(31-4)24(16-21)32-5;/h10-11,16-18,20H,9,12-15H2,1-8H3;1H
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/7510624
Sources: http://www.ncbi.nlm.nih.gov/pubmed/7510624
Gallopamil is a L-type calcium channel blocker designed for the treatment of coronary heart diseases: angina pectoris, prinzmetal angina and hypertonia.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095229 Sources: http://www.ncbi.nlm.nih.gov/pubmed/7510624 |
5.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | PROCORUM Approved UseUnknown |
|||
Primary | PROCORUM Approved UseUnknown |
|||
Primary | PROCORUM Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites. | 2000 Apr |
|
Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4. | 2001 Dec |
|
Imidazoline compounds protect against interleukin 1beta-induced beta-cell apoptosis. | 2001 Feb |
|
Calcium transients in subcompartments of the leech Retzius neuron as induced by single action potentials. | 2001 Jul |
|
Determination of fendiline and gallopamil by capillary isotachophoresis. | 2001 Jun 15 |
|
Progesterone effect mediated by the voltage-dependent calcium channel and protein kinase C on noncapacitated cryopreserved bovine spermatozoa. | 2001 Mar |
|
Left-to-right gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart. | 2001 May 29 |
|
Initial and sustained phases of myogenic response of rat mesenteric small arteries. | 2001 Nov |
|
Intracellular and extracellular calcium utilization during hypoxic vasoconstriction of cyclostome aortas. | 2001 Nov |
|
On the role of Ca(2+)- and voltage-dependent inactivation in Ca(v)1.2 sensitivity for the phenylalkylamine (-)gallopamil. | 2001 Oct 12 |
|
A large sustained Ca2+ elevation occurs in unstimulated spines during the LTP pairing protocol but does not change synaptic strength. | 2002 |
|
An increase in extracellular Ca(2+) concentration induces pigment aggregation in teleostean melanophores. | 2002 Aug |
|
A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients. | 2002 Aug |
|
Two types of ventricular fibrillation in isolated rabbit hearts: importance of excitability and action potential duration restitution. | 2002 Oct 1 |
|
Verapamil drug metabolism studies by automated in-tube solid phase microextraction. | 2002 Sep 5 |
|
Demonstration of direct bioanalysis of drugs in plasma using nanoelectrospray infusion from a silicon chip coupled with tandem mass spectrometry. | 2003 Feb 15 |
|
Characteristics of sperm motility induced on the egg-jelly in the internal fertilization of the newt, Cynops pyrrhogaster. | 2003 Mar |
|
A tale of two fibrillations. | 2003 Nov 11 |
|
Role of sarcoplasmic reticulum Ca2+ content in Ca2+ entry of bovine airway smooth muscle cells. | 2003 Oct |
|
[L-type calcium channels involvement in aortic smooth muscle contraction as revealed by membrane potential and active force dynamics]. | 2004 Apr-Jun |
|
Opposite effects of a single IIIS5 mutation on phenylalkylamine and dihydropyridine interaction with L-type Ca2+ channels. | 2004 Dec 31 |
|
Non-cross-bridge calcium-dependent stiffness in frog muscle fibers. | 2004 Jun |
|
NMDA receptor-mediated depolarizing after-potentials in the basal dendrites of CA1 pyramidal neurons. | 2004 Mar |
|
Mother rotors and the mechanisms of D600-induced type 2 ventricular fibrillation. | 2004 Oct 12 |
|
An ionic model for rhythmic activity in small clusters of embryonic chick ventricular cells. | 2005 Jul |
|
Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. | 2005 Jun |
|
Airway smooth muscle as a target of asthma therapy: history and new directions. | 2006 Sep 29 |
|
Ca2+ pathway involved in the refilling of store sites in rat adrenal medullary cells. | 2009 Apr |
|
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | 2010 Dec |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6367415
150 mg/day
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C333
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
56949-75-8
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
SUPERSEDED | |||
|
439837
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
PRIMARY | RxNorm | ||
|
16662-46-7
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
PRIMARY | |||
|
274966
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
PRIMARY | |||
|
C83726
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
PRIMARY | |||
|
VT4VR32A0T
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
PRIMARY | |||
|
240-704-7
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
PRIMARY | |||
|
DBSALT002564
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
PRIMARY | |||
|
119442
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
PRIMARY | |||
|
m5656
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID2047858
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
PRIMARY | |||
|
100000092331
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
PRIMARY | |||
|
SUB02309MIG
Created by
admin on Fri Dec 15 15:12:47 GMT 2023 , Edited by admin on Fri Dec 15 15:12:47 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD